Hebrew University Study Reveals Uneven Cellular Aging, Offering New Path to Cancer Prevention

A new study from the Hebrew University of Jerusalem demonstrates that biological aging is not uniform across the body. By analyzing single cells rather than tissue averages, researchers found that some cells age significantly faster than others due to uneven DNA methylation. This discovery challenges the traditional view of aging as a synchronized process and suggests that targeting specific 'elderly' cells could lead to new treatments for cancer and other age-related diseases.
Key points
- Researchers at the Hebrew University of Jerusalem and Hadassah University Medical Center published a study in Nature Communications showing that aging occurs at different speeds in individual cells.
- The study identifies a molecular 'aging signature' involving DNA methylation, where methyl groups act as switches to turn genes on or off.
- Lead researcher Prof. Howard Cedar notes that previous studies treated tissues as statistical averages, missing the fact that some cells accumulate age-related changes much faster than their neighbors.
- The findings suggest that targeting rapidly aging cells could help slow the aging process itself, rather than just treating resulting diseases like Alzheimer's or heart disease.
- The research builds on Cedar’s decades-long work in DNA methylation, which also underpins the Galleri test for early cancer detection.
Background
This research aligns with recent findings that younger cohorts may experience accelerated biological aging, increasing their risk for early-onset cancers. Previous studies have highlighted a growing gap between chronological and biological age in people born in the 1990s, linking this disparity to higher risks of lung, colorectal, and uterine cancers. While those studies focused on population-level trends, the current Hebrew University research provides a cellular-level explanation for why biological age varies, suggesting that the unevenness of aging at the single-cell level is a key driver of disease development.
How outlets are covering it
The Jerusalem Post emphasizes the fundamental shift in understanding aging as a 'mosaic' of young and old cells, highlighting the potential for new drugs that target specific aging mechanisms. In contrast, the Bluffton Icon focuses on practical, lifestyle-based approaches to slowing biological aging, citing a 2025 study that links omega-3 supplements, vitamin D, and exercise to reduced biological age. While the Jerusalem Post highlights a molecular mechanism for uneven aging, the Bluffton Icon suggests that external interventions can mitigate the overall pace of biological decline, though it does not address the cell-to-cell variability identified in the Hebrew University study.
Why it matters
Understanding that aging is uneven at the cellular level could revolutionize how we approach age-related diseases. Instead of treating symptoms or diseases that arise from aging, future therapies might target the specific cells that age fastest, potentially slowing the entire process. This could lead to earlier detection and prevention of conditions like cancer, which are often linked to abnormal DNA methylation patterns.
What to watch
Researchers will likely focus on identifying the specific molecular markers that cause some cells to age faster than others. This could lead to the development of targeted therapies that slow cellular aging or prevent the accumulation of age-related methylation changes. Additionally, the findings may inform the design of new early-detection tests that monitor biological age at the cellular level, rather than relying on tissue averages.
- Israeli study: Some body parts age faster, paving way for cancer treatment The Jerusalem Post
- Time in a Bottle: Biologic aging versus our actual age Bluffton Icon
Want the full story? Read the original reporting
Read on The Jerusalem Post